Gréen H - Search Results

1

In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia.

Skoglund K, Richter J, Olsson-Strömberg U, Bergquist J, Aluthgedara W, Ubhayasekera SJ, Vikingsson S, Svedberg A, Söderlund S, Sandstedt A, Johnsson A, Aagesen J, Alsenhed J, Hägg S, Peterson C, Lotfi K, Gréen H. Skoglund K, et al. Among authors: green h. Ther Drug Monit. 2016 Apr;38(2):230-8. doi: 10.1097/FTD.0000000000000268. Ther Drug Monit. 2016. PMID: 26693810 Free article.

2

Spontaneous reversal of p-glycoprotein expression in multidrug resistant cell lines.

Gréen H, Lotfi K, Zackrisson AL, Peterson C. Gréen H, et al. Pharmacol Toxicol. 2003 Dec;93(6):297-304. doi: 10.1111/j.1600-0773.2003.pto930608.x. Pharmacol Toxicol. 2003. PMID: 14675464

3

beta-Tubulin mutations in ovarian cancer using single strand conformation analysis-risk of false positive results from paraffin embedded tissues.

Gréen H, Rosenberg P, Söderkvist P, Horvath G, Peterson C. Gréen H, et al. Cancer Lett. 2006 May 8;236(1):148-54. doi: 10.1016/j.canlet.2005.05.025. Epub 2005 Jul 5. Cancer Lett. 2006. PMID: 16002208

4

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy.

Gréen H, Söderkvist P, Rosenberg P, Horvath G, Peterson C. Gréen H, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):854-9. doi: 10.1158/1078-0432.CCR-05-0950. Clin Cancer Res. 2006. PMID: 16467099 Clinical Trial.

5

Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface.

Gréen H, Vretenbrant K, Norlander B, Peterson C. Gréen H, et al. Rapid Commun Mass Spectrom. 2006;20(14):2183-9. doi: 10.1002/rcm.2567. Rapid Commun Mass Spectrom. 2006. PMID: 16791868

6

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

Gréen H, Söderkvist P, Rosenberg P, Horvath G, Peterson C. Gréen H, et al. J Pharm Sci. 2008 Jun;97(6):2045-8. doi: 10.1002/jps.21169. J Pharm Sci. 2008. PMID: 17828752 Free article.

7

Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.

Gréen H, Söderkvist P, Rosenberg P, Mirghani RA, Rymark P, Lundqvist EA, Peterson C. Gréen H, et al. Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):130-7. doi: 10.1111/j.1742-7843.2008.00351.x. Epub 2008 Dec 16. Basic Clin Pharmacol Toxicol. 2009. PMID: 19143748 Free article.

8

CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity.

Gréen H, Skoglund K, Rommel F, Mirghani RA, Lotfi K. Gréen H, et al. Eur J Clin Pharmacol. 2010 Apr;66(4):383-6. doi: 10.1007/s00228-009-0772-y. Eur J Clin Pharmacol. 2010. PMID: 20054526 Free article.

9

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.

Gréen H, Falk IJ, Lotfi K, Paul E, Hermansson M, Rosenquist R, Paul C, Nahi H. Gréen H, et al. Pharmacogenomics J. 2012 Apr;12(2):111-8. doi: 10.1038/tpj.2010.79. Epub 2010 Oct 12. Pharmacogenomics J. 2012. PMID: 20938465

10

Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer.

Gréen H, Khan MS, Jakobsen-Falk I, Åvall-Lundqvist E, Peterson C. Gréen H, et al. J Pharm Sci. 2011 Oct;100(10):4205-9. doi: 10.1002/jps.22680. Epub 2011 Jun 23. J Pharm Sci. 2011. PMID: 21702053 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,792 results

Search Page